RevolKa Ltd., a venture-backed biotech company providing a protein engineering technology platform, has signed a master service agreement with Daiichi Sankyo Co., Ltd., under which RevolKa will create and deliver highly functional proteins in collaboration with Daiichi Sankyo Co., Ltd. by using its proprietary protein engineering platform technology, called aiProtein
 
RevolKa’s proprietary technology, aiProtein is a directed protein evolution technology integrated with artificial intelligence (AI). Its AI engine is trained with sequence-function relationship data to statistically predict sequences for an evolved protein function. Furthermore, aiProtein can evolve more than two functions simultaneously. This technology is a powerful and cost-effective tool for the creation of novel and highly-optimized proteins for pharmaceutical and industrial uses.